BCWORLD PHARM. Co. Ltd (200780) — Capital Reinvestment Ratio
BCWORLD PHARM. Co. Ltd (200780) has a Capital Reinvestment Ratio of 1.14x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.43 Billion) in capital expenditures (₩1.63 Billion). See BCWORLD PHARM. Co. Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BCWORLD PHARM. Co. Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks BCWORLD PHARM. Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. Check total reinvestment intensity of BCWORLD PHARM. Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for BCWORLD PHARM. Co. Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for BCWORLD PHARM. Co. Ltd from 2015 to 2024. For live market cap and broader valuation context, see how much is BCWORLD PHARM. Co. Ltd worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.60x | ₩4.04 Billion | ₩2.41 Billion | ▲ +140.5% |
| 2023 | 0.25x | ₩10.94 Billion | ₩2.71 Billion | ▼ -72.6% |
| 2022 | 0.90x | ₩6.88 Billion | ₩6.22 Billion | ▼ -48.7% |
| 2019 | 1.76x | ₩12.11 Billion | ₩21.32 Billion | ▼ -68.6% |
| 2018 | 5.60x | ₩5.34 Billion | ₩29.92 Billion | ▲ +167.0% |
| 2017 | 2.10x | ₩7.90 Billion | ₩16.58 Billion | ▼ -95.9% |
| 2016 | 51.55x | ₩243.66 Million | ₩12.56 Billion | ▲ +1692.4% |
| 2015 | 2.88x | ₩8.78 Billion | ₩25.26 Billion | — |